研究单位：[1]Allergan[2]Tongji Hospital of Tongji Medical College, Huazhong University of Science & Technology[3]Beijing Hospital[4]Xuanwu Hospital Capital Medical University
研究目的：
A study to evaluate the long-term safety of GANFORT® (bimatoprost 0.03% plus timolol 0.5%) in Chinese patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to topical beta-blocker or prostaglandin analogues.
